News | Clinical Decision Support | November 17, 2017

HealthMyne Highlights Value of Quantitative Data in Oncology Reads at RSNA 2017

HealthMyne Platform provides consistent, automated measurements and streamlines reading and reporting workflows

HealthMyne Highlights Value of Quantitative Data in Oncology Reads at RSNA 2017

November 17, 2017 — At the 2017 Radiological Society of North America (RSNA) conference, HealthMyne will demonstrate the value of including quantitative data on every oncology read with its HealthMyne Platform.

Even if a patient and their doctor have an idea that something is wrong, the story only begins when a radiologist declares that an abnormality seen on an image is cancer. The information contained in the initial and follow-up reports is used to determine the patient’s progress and therefore needs to be as comprehensive, precise and consistent as possible.

In the HealthMyne Platform, a simple mouse gesture, similar to pulling a measurement, provides radiologists with consistent long and short values that flow to the radiology report in a structured format so there is no need to dictate numbers. Follow-up cases are simplified by automatically opening and registering prior image sets. All previously identified lesions are also propagated to the current images with long and short measurements ascertained and awaiting approval.  

Beyond the report, the quantitative measurements in the HealthMyne Platform are utilized in a variety of ways to increase radiology and the multidisciplinary care team’s value across the enterprise, including: streamlined tumor board preparation and management of these sessions; efficient management of the complex therapy response for clinical trials process; and real-time Incidental Findings documentation, follow-up, scheduling and tracking.

For more information: www.healthmyne.com

Related Content

Video Plus Brochure Helps Patients Make Lung Cancer Scan Decision

Image courtesy of the American Thoracic Society

News | Lung Cancer | April 19, 2019
A short video describing the potential benefits and risks of low-dose computed tomography (CT) screening for lung...
Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer
News | Artificial Intelligence | April 18, 2019
University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to...
Videos | Breast Imaging | April 18, 2019
In a keynote lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, ...
Check-Cap Initiates U.S. Pilot Study of C-Scan for Colorectal Cancer Screening
News | Colonoscopy Systems | April 15, 2019
Check-Cap Ltd. has initiated its U.S. pilot study of the C-Scan system for prevention of colorectal cancer through...
Cambridge University Hospitals NHS Foundation Trust Implements Change Healthcare Enterprise Imaging
News | Enterprise Imaging | April 15, 2019
Change Healthcare successfully implemented its Radiology PACS (picture archiving and communication system), Image...
vRad Receives 19th Patent
News | Teleradiology | April 10, 2019
vRad (Virtual Radiologic), a Mednax Radiology Solutions practice, announced that the U.S. Patent and Trademark Office...
Visage 7 Enterprise Imaging Platform Highlighted at 2019 SBI/ACR Breast Imaging Symposium
News | Enterprise Imaging | April 05, 2019
Visage Imaging will be exhibiting the latest version of the Visage 7 Enterprise Imaging Platform at the 2019 Society of...
Konica Minolta Highlights New Exa Mammo Features at SBI/ACR Breast Imaging Symposium
News | Breast Imaging | April 03, 2019
Konica Minolta Healthcare Americas Inc. will highlight new features of Exa Mammo, a picture archiving and communication...
Lunit Showcases AI Solution for Breast Cancer at SBI 2019
News | Artificial Intelligence | April 02, 2019
Medical artificial intelligence (AI) startup Lunit announced its attendance at the Society of Breast Imaging (SBI) 2019...